Stocktoria
CSL Limited CSL.AX
CSL Limited (CSL.AX) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 2.54% (safety: moderate). FY2025 revenue was $15.4B at a 19.5% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 36 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.179 |
| Retained earnings / assets | 0.45 |
| EBIT / assets | 0.075 |
| Equity / liabilities | 1.074 |
FAQ
Is CSL.AX financially healthy?
CSL Limited's Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does CSL.AX pay a dividend, and is it safe?
Yes. CSL Limited pays a dividend yielding about 2.54% with a 47.8% payout ratio, rated “moderate” for safety.
How profitable is CSL.AX?
In FY2025, CSL Limited had a net margin of 19.5% and a return on equity of 15.5%.
Source: company filings via Yahoo Finance · AU · as of 2025-06-30. Figures in AUD; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.